Two organisations which were introduced via Medilink East Midlands (EM) have joined in an exciting collaboration which has the potential to benefit hundreds of children and families in India, and even save lives. “A Germ’s Journey” is a project led by Dr Katie Laird and her colleagues at De Montfort...
Upperton Pharma Solutions expands to offer cGMP spray drying and clinical trials manufacturing service
Upperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP manufacturing capabilities for early phase...
Changes to fees for UK patent applications from 6 April 2018
The UK Intellectual Property Office (UKIPO) has recently announced that it will be increasing the official fees on UK patent applications on 6 April 2018 as well as some of the renewal fees needed to keep granted UK patents in force. In short, the fee increases will be relatively small...
Leicester Arena and Morningside Pharmaceuticals announce partnership
Leicester Arena and Morningside Pharmaceuticals have agreed a three year naming rights sponsorship for the arena, which will henceforth be called the Morningside Arena, Leicester. The 3,000 capacity arena is the largest in Leicester, and, as well as being the home of the national basketball Club champions, the Leicester Riders,...
Charnwood Molecular collaboration with Forendo Pharma provides Development candidates
A two-year-long discovery chemistry collaboration between Charnwood Molecular and Forendo Pharma has seen compounds move from discovery to pre-clinical development. Charnwood Molecular and Forendo Pharma have been collaborating since September 2015, with Charnwood Molecular synthesising challenging steroidal analogues of a hit compound initially identified at Forendo Pharma. Multi-centred lead optimisation...
Launch of new collaboration to tackle lung disease
Leicester and Nottingham universities have announced a new strategic research collaboration with GSK, using genetics to aid the development of new medicines for Chronic Obstructive Pulmonary Disease (COPD) and related airway disorders. The £1.24m investment over three years provides an East Midlands-focused boost to the Life Sciences Sector Deal of...
Local deaf charity’s marathon staff challenge
One of The Ear Foundation’s own team has decided to take on the mammoth challenge of running The London Marathon in support of the charity she works for. Sarah Hoyle has bravely decided to take up the challenge and will be running the world renowned marathon in the capital on...
Locate Therapeutics Successfully Achieves ISO 13845 Certification for Design, Development and Control of Manufacture for Resorbable Biomaterials
Locate Therapeutics, a leading UK regenerative medicine company has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration. Currently Locate is developing a pipeline of combination therapies using its patented TAOS®* polymer-based matrix as a...
XenoGesis moves into BioHub as expansion plans continue
Leading UK-based DMPK provider has taken tenancy at BioHub, Alderley Park, increasing its foothold in the UK. XenoGesis which was founded in 2011 by Dr Richard Weaver, has seen continued growth at its headquarters at BioCity Nottingham. Now employing 25 members of staff, the business has steadily grown into larger...
£500k Funding Boost for Regenerative Medicine Firm
A regenerative medicine company which has developed a therapy that can help prevent sight loss has completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will allow Nottingham-based NuVision Biotherapies to further develop its product range, add to its management...
